Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 2
1(25.0%)
Phase 3
1(25.0%)
4Total
N/A(2)
Phase 2(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03381794Recruiting

The German Keratoplasty Registry of the German Ophthalmological Society (DOG)

Role: collaborator

NCT03865160Phase 2Active Not Recruiting

Low-dose Atropine for Myopia Control in Children

Role: lead

NCT05399095Not ApplicableCompleted

Supine Positioning for Graft Attachment After Descemet Membrane Endothelial Keratoplasty

Role: lead

NCT04140422Not ApplicableCompleted

Eye Drops for Early Morning-Associated Corneal Swelling of the Cornea

Role: lead

NCT01962571Phase 3Completed

Treatment of Optic Neuritis With Erythropoietin: a Randomised, Double-blind, Placebo-controlled Trial

Role: lead

All 5 trials loaded